User profiles for Carla Usai
 | Carla UsaiPostdoctoral Researcher at IRTA - CReSA (Spain) Verified email at irta.cat Cited by 196 |
[PDF][PDF] Differential immunogenicity of homologous versus heterologous boost in Ad26. COV2. S vaccine recipients
Background Protection offered by coronavirus disease 2019 (COVID-19) vaccines wanes
over time, requiring an evaluation of different boosting strategies to revert such a trend and …
over time, requiring an evaluation of different boosting strategies to revert such a trend and …
Immunisation efficacy of a stabilised SARS-CoV-2 spike glycoprotein in two geriatric animal models
Age is associated with reduced efficacy of vaccines and linked to higher risk of severe
COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 vaccine …
COVID-19. Here we determined the impact of ageing on the efficacy of a SARS-CoV-2 vaccine …
[HTML][HTML] Emerging insights into the immunopathology, clinical and therapeutic aspects of hepatitis delta virus
Background Hepatitis delta virus (HDV), which causes the most severe form of viral hepatitis,
is an obligated hepatitis B (HBV) satellite virus that can either infect naïve subjects …
is an obligated hepatitis B (HBV) satellite virus that can either infect naïve subjects …
[HTML][HTML] TNF-alpha inhibition ameliorates HDV-induced liver damage in a mouse model of acute severe infection
C Usai, S Maestro, G Camps, C Olague… - JHEP reports, 2020 - Elsevier
Background & Aims HDV infection induces the most severe form of human viral hepatitis.
However, the specific reasons for the severity of the disease remain unknown. Recently, we …
However, the specific reasons for the severity of the disease remain unknown. Recently, we …
A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction
L Suárez-Amarán, C Usai, M Di Scala, C Godoy… - Journal of …, 2017 - Elsevier
Background & Aims Studying hepatitis delta virus (HDV) and developing new treatments is
hampered by the limited availability of small animal models. Herein, a description of a robust …
hampered by the limited availability of small animal models. Herein, a description of a robust …
The β-NGF/TrkA signalling pathway is associated with the production of anti-nucleoprotein IgG in convalescent COVID-19
Background The presentation of SARS-CoV-2 infection varies from asymptomatic to severe
COVID-19. Similarly, high variability in the presence, titre and duration of specific antibodies …
COVID-19. Similarly, high variability in the presence, titre and duration of specific antibodies …
Animal models to study the neurological manifestations of the post-COVID-19 condition
More than 40% of individuals infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have experienced persistent or relapsing multi-systemic symptoms months …
have experienced persistent or relapsing multi-systemic symptoms months …
[HTML][HTML] β-Cyclodextrins as affordable antivirals to treat coronavirus infection
The SARS-CoV-2 pandemic made evident that there are only a few drugs against coronavirus.
Here we aimed to identify a cost-effective antiviral with broad spectrum activity and high …
Here we aimed to identify a cost-effective antiviral with broad spectrum activity and high …
Characterization of a mouse model for the study of hepatitis delta virus infection
C Usai - 2018 - dadun.unav.edu
Hepatitis delta virus (HDV) is a defective RNA virus that depends on hepatitis B virus (HBV)
for the formation of new virions. HDV induces the most severe form of human viral hepatitis …
for the formation of new virions. HDV induces the most severe form of human viral hepatitis …
Agreement and differential use of laboratory methods for the detection and quantification of SARS-CoV-2 in experimentally infected animals
C Usai, L Pailler-García, C Lorca-Oró… - Frontiers in …, 2022 - frontiersin.org
Rodents are widely used for the development of COVID-19-like animal models, the virological
outcome being determined through several laboratory methods reported in the literature. …
outcome being determined through several laboratory methods reported in the literature. …
